Nature Communications (Oct 2024)

Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson syndrome and toxic epidermal necrolysis

  • Andrew Gibson,
  • Ramesh Ram,
  • Rama Gangula,
  • Yueran Li,
  • Eric Mukherjee,
  • Amy M. Palubinsky,
  • Chelsea N. Campbell,
  • Michael Thorne,
  • Katherine C. Konvinse,
  • Phuti Choshi,
  • Pooja Deshpande,
  • Sarah Pedretti,
  • Mark W. Fear,
  • Fiona M. Wood,
  • Richard T. O’Neil,
  • Celestine N. Wanjalla,
  • Spyros A. Kalams,
  • Silvana Gaudieri,
  • Rannakoe J. Lehloenya,
  • Samuel S. Bailin,
  • Abha Chopra,
  • Jason A. Trubiano,
  • On behalf of the AUS-SCAR Consortium,
  • Jonny G. Peter,
  • On behalf of the AFRiSCAR Consortium,
  • Simon A. Mallal,
  • Elizabeth J. Phillips

DOI
https://doi.org/10.1038/s41467-024-52990-3
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is a rare but life-threatening cutaneous drug reaction mediated by human leukocyte antigen (HLA) class I-restricted CD8+ T cells. For unbiased assessment of cellular immunopathogenesis, here we perform single-cell (sc) transcriptome, surface proteome, and T cell receptor (TCR) sequencing on unaffected skin, affected skin, and blister fluid from 15 SJS/TEN patients. From 109,888 cells, we identify 15 scRNA-defined subsets. Keratinocytes express markers indicating HLA class I-restricted antigen presentation and appear to trigger the proliferation of and killing by cytotoxic CD8+ tissue-resident T cells that express granulysin, granzyme B, perforin, LAG3, CD27, and LINC01871, and signal through the PKM, MIF, TGFβ, and JAK-STAT pathways. In affected tissue, cytotoxic CD8+ T cells express private expanded and unexpanded TCRαβ that are absent or unexpanded in unaffected skin, and mixed populations of macrophages and fibroblasts express pro-inflammatory markers or those favoring repair. This data identifies putative cytotoxic TCRs and therapeutic targets.